InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,062.00
(
-0.10%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
66,969.80
(
0.04%
)
Post# of 251859
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Tuesday, 04/01/2014 9:06:02 AM

Tuesday, April 01, 2014 9:06:02 AM

Post# of 251859
Judge affirms patent on Eli Lilly lung-cancer drug
A district judge has upheld the validity of a patent on Eli Lilly's (LLY) blockbuster Alimta lung-cancer drug, which generates sales of $2.6B a year.
The decision will maintain the treatment's exclusivity until 2022, pending the outcome of any appeal.
Companies on the losing side in the case include Teva (TEVA) and Fresenius Kabi (APCVZ).
http://seekingalpha.com/pr/9427913-u-s-district-court-upholds-validity-of-lillys-alimta-patent-through-2022
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up